Dyslipidaemia and mortality in COVID-19 patients: a meta-analysis.
M ZuinG RigatelliClaudio BilatoC CervellatiG ZulianiLoris RonconPublished in: QJM : monthly journal of the Association of Physicians (2021)
Dyslipidaemia represents a major comorbidity in about 18% of COVID-19 patients but it is associated with a 60% increase of short-term mortality risk.